EAU guidelines on renal cell carcinoma: 2014 update B Ljungberg, K Bensalah, S Canfield, S Dabestani, F Hofmann, M Hora, ... European urology 67 (5), 913-924, 2015 | 3027 | 2015 |
EAU guidelines on renal cell carcinoma: the 2010 update B Ljungberg, NC Cowan, DC Hanbury, M Hora, MA Kuczyk, ... European urology 58 (3), 398-406, 2010 | 1834 | 2010 |
European association of urology guidelines on renal cell carcinoma: the 2019 update B Ljungberg, L Albiges, Y Abu-Ghanem, K Bensalah, S Dabestani, ... European urology 75 (5), 799-810, 2019 | 1347 | 2019 |
European Association of Urology guidelines on renal cell carcinoma: the 2022 update B Ljungberg, L Albiges, Y Abu-Ghanem, J Bedke, U Capitanio, ... European urology 82 (4), 399-410, 2022 | 749 | 2022 |
Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy L Marconi, S Dabestani, TB Lam, F Hofmann, F Stewart, J Norrie, A Bex, ... European urology 69 (4), 660-673, 2016 | 584 | 2016 |
Guidelines on renal cell carcinoma B Ljungberg, K Bensalah, A Bex, S Canfield, S Dabestani, F Hofmann, ... European association of urology 14, 2015 | 494 | 2015 |
Updated European Association of Urology guidelines on renal cell carcinoma: immune checkpoint inhibition is the new backbone in first-line treatment of metastatic clear-cell … L Albiges, T Powles, M Staehler, K Bensalah, RH Giles, M Hora, ... European urology 76 (2), 151-156, 2019 | 210 | 2019 |
Updated European Association of Urology Guidelines: recommendations for the treatment of first-line metastatic clear cell renal cancer T Powles, L Albiges, M Staehler, K Bensalah, S Dabestani, RH Giles, ... European urology 73 (3), 311-315, 2018 | 206 | 2018 |
Mixed epithelial and stromal tumors of the kidney. A report of 22 cases M Michal, O Hes, M Bisceglia, RHW Simpson, DV Spagnolo, A Parma, ... Virchows Archiv 445, 359-367, 2004 | 178 | 2004 |
Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases F Petersson, Z Gatalica, P Grossmann, MD Perez Montiel, ... Virchows Archiv 456, 355-365, 2010 | 162 | 2010 |
A systematic review and meta-analysis comparing the effectiveness and adverse effects of different systemic treatments for non-clear cell renal cell carcinoma S Fernandez-Pello, F Hofmann, R Tahbaz, L Marconi, TB Lam, L Albiges, ... European urology 71 (3), 426-436, 2017 | 153 | 2017 |
Spindle and cuboidal renal cell carcinoma, a tumour having frequent association with nephrolithiasis: report of 11 cases including a case with hybrid conventional renal cell … O Hes, M Hora, DM Perez‐Montiel, S Suster, R Curik, L Sokol, O Ondic, ... Histopathology 41 (6), 549-555, 2002 | 143 | 2002 |
Oncocytic papillary renal cell carcinoma: a clinicopathologic, immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases O Hes, M Brunelli, M Michal, PC Rocca, M Hora, M Chilosi, M Mina, ... Annals of diagnostic pathology 10 (3), 133-139, 2006 | 139 | 2006 |
Niraparib and abiraterone acetate for metastatic castration-resistant prostate cancer KN Chi, D Rathkopf, MR Smith, E Efstathiou, G Attard, D Olmos, JY Lee, ... Journal of Clinical Oncology 41 (18), 3339-3351, 2023 | 135 | 2023 |
Updated EAU Guidelines for Clear Cell Renal Cancer Patients Who Fail VEGF Targeted Therapy. T Powles, M Staehler, B Ljungberg, K Bensalah, SE Canfield, ... European urology 69 (1), 4-6, 2015 | 135 | 2015 |
The 2021 updated European association of urology guidelines on renal cell carcinoma: Immune checkpoint inhibitor–based combination therapies for treatment-naive metastatic … J Bedke, L Albiges, U Capitanio, RH Giles, M Hora, TB Lam, B Ljungberg, ... European Urology 80 (4), 393-397, 2021 | 131 | 2021 |
Updated European Association of Urology guidelines on renal cell carcinoma: nivolumab plus cabozantinib joins immune checkpoint inhibition combination therapies for treatment … J Bedke, L Albiges, U Capitanio, RH Giles, M Hora, TB Lam, B Ljungberg, ... European urology 79 (3), 339-342, 2021 | 123 | 2021 |
Renal angiomyoadenomatous tumor: morphologic, immunohistochemical, and molecular genetic study of a distinct entity M Michal, O Hes, J Nemcova, R Sima, N Kuroda, S Bulimbasic, M Franco, ... Virchows Archiv 454, 89-99, 2009 | 115 | 2009 |
Systematic review of surgical management of nonmetastatic renal cell carcinoma with vena caval thrombus M Lardas, F Stewart, D Scrimgeour, F Hofmann, L Marconi, S Dabestani, ... European urology 70 (2), 265-280, 2016 | 114 | 2016 |
Management of sporadic renal angiomyolipomas: a systematic review of available evidence to guide recommendations from the European Association of Urology Renal Cell Carcinoma … S Fernández-Pello, M Hora, T Kuusk, R Tahbaz, S Dabestani, ... European urology oncology 3 (1), 57-72, 2020 | 101 | 2020 |